Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Apogee Therapeutics Logo
Apogee Therapeutics Growth Score
86
CB Rank
681
Heat Score
95
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
Founded
obfuscation
PublicPost-IPO Debt San Francisco, California, United States251-500 apogeetherapeutics.com/
Biotechnology
Life Science
Medical
Therapeutics
Overview

Apogee Therapeutics
Total Funding
obfuscation
Growth Score
86
Heat Score
95

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score86
8 pts
in past quarter
Heat Score 95
34 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Apogee Therapeutics

CB Rank
681
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
Founded
obfuscation
PublicPost-IPO Debt San Francisco, California, United States251-500 apogeetherapeutics.com/
Biotechnology
Life Science
Medical
Therapeutics

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Apogee Therapeutics, Inc.
Operating Status Active
Stock Symbol  NASDAQ:APGE
Company Type For Profit
Founders  Nimish Shah
About the Company
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders. The company aims to advance novel therapies to address patients’ needs. Based in San Francisco, California, Apogee Therapeutics was founded in 2022.
Predictions & Insights

Growth Insight

See this Growth Insight
Apogee Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

APG333
A half-life extended TSLP antibody designed for treating respiratory and other immunological and inflammatory conditions.
APG777
An antibody therapeutic targeting IL-13 for the treatment of atopic dermatitis.

Research & Development

Apogee Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Apogee Therapeutics Logo
Post-IPO Debt - Apogee Therapeutics
1
obfuscation
Blackstone Life SciencesPost-IPO Debt
obfuscation
Post-IPO Debt - Apogee Therapeutics Logo
Post-IPO Debt - Apogee Therapeutics
1
obfuscation
Blackstone Life SciencesPost-IPO Debt
obfuscation
Post-IPO Debt - Apogee Therapeutics Logo
Post-IPO Debt - Apogee Therapeutics
1
obfuscation
Blackstone Life SciencesPost-IPO Debt
obfuscation
Post-IPO Debt - Apogee Therapeutics Logo
Post-IPO Debt - Apogee Therapeutics
1
obfuscation
Blackstone Life SciencesPost-IPO Debt
obfuscation
Post-IPO Debt - Apogee Therapeutics Logo
Post-IPO Debt - Apogee Therapeutics
1
obfuscation
Blackstone Life SciencesPost-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Apogee Therapeutics Logo
Post-IPO Debt - Apogee Therapeutics
1
obfuscation
Blackstone Life SciencesPost-IPO Debt
obfuscation
Post-IPO Debt - Apogee Therapeutics Logo
Post-IPO Debt - Apogee Therapeutics
1
obfuscation
Blackstone Life SciencesPost-IPO Debt
obfuscation
Post-IPO Debt - Apogee Therapeutics Logo
Post-IPO Debt - Apogee Therapeutics
1
obfuscation
Blackstone Life SciencesPost-IPO Debt
obfuscation
Post-IPO Debt - Apogee Therapeutics Logo
Post-IPO Debt - Apogee Therapeutics
1
obfuscation
Blackstone Life SciencesPost-IPO Debt
obfuscation
Post-IPO Debt - Apogee Therapeutics Logo
Post-IPO Debt - Apogee Therapeutics
1
obfuscation
Blackstone Life SciencesPost-IPO Debt

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 251-500 Employee Profiles 4 Board Members and Advisors 2 Contacts 110

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 1, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 30, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

15,038
37.53%
 in past month

IT Spend

$401.2KThis year, Apogee Therapeutics is projected to spend $401.2K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Hedge Fund Management Software Logo
Hedge Fund Management Software
100
Financial Services Logo
Financial Services
98
Reuters Logo
Reuters
95

Active Website Tech Count

13Apogee Therapeutics is actively using 13 technologies for its website, according to BuiltWith. These include DNSSEC, CommonCrawl Top 5m, and  Java EE.
Sub-Organizations
Frequently Asked Questions

Where is Apogee Therapeutics's headquarters? Apogee Therapeutics is located in San Francisco, California, United States.Who invested in Apogee Therapeutics? Apogee Therapeutics has 11 investors including Blackstone Life Sciences and  Access Industries.When was the last funding round for Apogee Therapeutics? Apogee Therapeutics closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Apogee Therapeutics's competitors? Alternatives and possible competitors to Apogee Therapeutics may include BioAge Labs, Q32 Bio, and  Alumis.How much funding has Apogee Therapeutics raised to date? Apogee Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|